Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1995 Jul;101(Suppl 1):15–17. doi: 10.1111/j.1365-2249.1995.tb06155.x

The diversity of perinuclear antineutrophil cytoplasmic antibodies (pANCA) antigens.

A Wiik 1, L Stummann 1, L Kjeldsen 1, N Borregaard 1, S Ullman 1, S Jacobsen 1, P Halberg 1
PMCID: PMC1553555  PMID: 7541732

Full text

PDF
17

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baslund B., Wiik A. Anti-neutrophil cytoplasmic autoantibodies (ANCA) and vasculitis. Clin Rev Allergy. 1994 Fall;12(3):297–304. doi: 10.1007/BF02802324. [DOI] [PubMed] [Google Scholar]
  2. Brouwer E., Huitema M. G., Mulder A. H., Heeringa P., van Goor H., Tervaert J. W., Weening J. J., Kallenberg C. G. Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. Kidney Int. 1994 Apr;45(4):1120–1131. doi: 10.1038/ki.1994.149. [DOI] [PubMed] [Google Scholar]
  3. Coremans I. E., Hagen E. C., Daha M. R., van der Woude F. J., van der Voort E. A., Kleijburg-van der Keur C., Breedveld F. C. Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum. 1992 Dec;35(12):1466–1475. doi: 10.1002/art.1780351210. [DOI] [PubMed] [Google Scholar]
  4. Davies D. J., Moran J. E., Niall J. F., Ryan G. B. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? 1982 Aug 28-Sep 4Br Med J (Clin Res Ed) 285(6342):606–606. doi: 10.1136/bmj.285.6342.606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dolman K. M., Gans R. O., Vervaat T. J., Zevenbergen G., Maingay D., Nikkels R. E., Donker A. J., von dem Borne A. E., Goldschmeding R. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet. 1993 Sep 11;342(8872):651–652. doi: 10.1016/0140-6736(93)91761-a. [DOI] [PubMed] [Google Scholar]
  6. Ellerbroek P. M., Oudkerk Pool M., Ridwan B. U., Dolman K. M., von Blomberg B. M., von dem Borne A. E., Meuwissen S. G., Goldschmeding R. Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis. J Clin Pathol. 1994 Mar;47(3):257–262. doi: 10.1136/jcp.47.3.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Falk R. J., Becker M., Terrell R., Jennette J. C. Anti-myeloperoxidase autoantibodies react with native but not denatured myeloperoxidase. Clin Exp Immunol. 1992 Aug;89(2):274–278. doi: 10.1111/j.1365-2249.1992.tb06944.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Falk R. J., Jennette J. C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med. 1988 Jun 23;318(25):1651–1657. doi: 10.1056/NEJM198806233182504. [DOI] [PubMed] [Google Scholar]
  9. Gross W. L., Schmitt W. H., Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol. 1993 Jan;91(1):1–12. doi: 10.1111/j.1365-2249.1993.tb03345.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Halbwachs-Mecarelli L., Nusbaum P., Noël L. H., Reumaux D., Erlinger S., Grünfeld J. P., Lesavre P. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol. 1992 Oct;90(1):79–84. doi: 10.1111/j.1365-2249.1992.tb05835.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jennette J. C., Falk R. J., Andrassy K., Bacon P. A., Churg J., Gross W. L., Hagen E. C., Hoffman G. S., Hunder G. G., Kallenberg C. G. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994 Feb;37(2):187–192. doi: 10.1002/art.1780370206. [DOI] [PubMed] [Google Scholar]
  12. Kallenberg C. G., Brouwer E., Weening J. J., Tervaert J. W. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int. 1994 Jul;46(1):1–15. doi: 10.1038/ki.1994.239. [DOI] [PubMed] [Google Scholar]
  13. Lee S. S., Adu D., Thompson R. A. Anti-myeloperoxidase antibodies in systemic vasculitis. Clin Exp Immunol. 1990 Jan;79(1):41–46. doi: 10.1111/j.1365-2249.1990.tb05124.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lee S. S., Lawton J. W., Chan C. E., Li C. S., Kwan T. H., Chau K. F. Antilactoferrin antibody in systemic lupus erythematosus. Br J Rheumatol. 1992 Oct;31(10):669–673. doi: 10.1093/rheumatology/31.10.669. [DOI] [PubMed] [Google Scholar]
  15. Mulder A. H., Horst G., Haagsma E. B., Limburg P. C., Kleibeuker J. H., Kallenberg C. G. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology. 1993 Mar;17(3):411–417. [PubMed] [Google Scholar]
  16. Mulder A. H., Horst G., van Leeuwen M. A., Limburg P. C., Kallenberg C. G. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Characterization and clinical correlations. Arthritis Rheum. 1993 Aug;36(8):1054–1060. doi: 10.1002/art.1780360805. [DOI] [PubMed] [Google Scholar]
  17. Nielsen H., Wiik A., Elmgreen J. Granulocyte specific antinuclear antibodies in ulcerative colitis. Aid in differential diagnosis of inflammatory bowel disease. Acta Pathol Microbiol Immunol Scand C. 1983 Feb;91(1):23–26. [PubMed] [Google Scholar]
  18. Nässberger L., Sjöholm A. G., Jonsson H., Sturfelt G., Akesson A. Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus. Clin Exp Immunol. 1990 Sep;81(3):380–383. doi: 10.1111/j.1365-2249.1990.tb05342.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Roberts D. E., Peebles C., Curd J. G., Tan E. M., Rubin R. L. Autoantibodies to native myeloperoxidase in patients with pulmonary hemorrhage and acute renal failure. J Clin Immunol. 1991 Nov;11(6):389–397. doi: 10.1007/BF00918805. [DOI] [PubMed] [Google Scholar]
  20. Savage C. O., Winearls C. G., Jones S., Marshall P. D., Lockwood C. M. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet. 1987 Jun 20;1(8547):1389–1393. doi: 10.1016/s0140-6736(87)90591-5. [DOI] [PubMed] [Google Scholar]
  21. Schmitt W. H., Csernok E., Flesch B. K., Hauschild S., Gross W. L. Autoantibodies directed against lysozyme: a new target antigen for anti-neutrophil cytoplasmic antibodies (ANCA). Adv Exp Med Biol. 1993;336:267–272. doi: 10.1007/978-1-4757-9182-2_40. [DOI] [PubMed] [Google Scholar]
  22. Weiss S. J. Tissue destruction by neutrophils. N Engl J Med. 1989 Feb 9;320(6):365–376. doi: 10.1056/NEJM198902093200606. [DOI] [PubMed] [Google Scholar]
  23. Wiik A. Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis. Clin Exp Rheumatol. 1993 Mar-Apr;11(2):191–201. [PubMed] [Google Scholar]
  24. Wiik A. Granulocyte-specific antinuclear antibodies. Possible significance for the pathogenesis, clinical features and diagnosis of rheumatoid arthritis. Allergy. 1980 Jun;35(4):263–289. doi: 10.1111/j.1398-9995.1980.tb01768.x. [DOI] [PubMed] [Google Scholar]
  25. Wiik A., van der Woude F. J. The new ACPA/ANCA nomenclature. Neth J Med. 1990 Apr;36(3-4):107–108. [PubMed] [Google Scholar]
  26. van der Woude F. J., Rasmussen N., Lobatto S., Wiik A., Permin H., van Es L. A., van der Giessen M., van der Hem G. K., The T. H. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. 1985 Feb 23;1(8426):425–429. doi: 10.1016/s0140-6736(85)91147-x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES